Identification of Proteins Associated with the Intracellular Degradation of Misfolded Clotting Factors
Identification of Proteins Associated with the Intracellular Degradation of Misfolded Clotting Factors
批准号:
08680698
负责人:
TOKUNAGA Fuminori
金额:
$1.54万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
我们已经证明,在口服抗凝剂华法林存在下合成的维生素K依赖性凝血因子通过内质网(ER)中的质量控制机制在细胞内降解。这是药物诱导的ER相关降解的唯一模型。1996年,我们发现在华法林存在下合成的细胞内蛋白C在细胞内降解过程中与ER分子伴侣如GRP 94、GRP 78(BiP)和钙网蛋白相关。蛋白酶体抑制剂如lactacystin和Z-leu-Leu-Leu-H可抑制华法林诱导的蛋白C降解,提示蛋白酶体通过逆行转运将羧基化不足的蛋白C降解。1997年,我们比较了维生素K依赖蛋白对华法林的敏感性。在华法林存在下,HepG 2细胞中合成的蛋白C被广泛降解,而约50%的凝血酶原被分泌到培养基中。因此,我们构建了两个嵌合体的蛋白C具有凝血酶原Gla域(GDII/PC)和具有凝血酶原Gladomain的前原序列(PPGDII/PC),并使用BHK细胞检测嵌合体的分泌。出乎意料的是,即使在维生素K存在下,两种嵌合蛋白也不分泌。嵌合体的γ-羧化正常发生。这些结果表明,不仅Gla结构域的γ-羧化,而且某些Gla结构域与其它结构域的相互作用也是维生素K依赖蛋白质质量控制的重要因素。
英文摘要
We have shown that the vitamin K-dependent coagulation factors synthesized in the presence of warfarin, an oral anticoagulant, is degraded intracellularly through the quality control mechanism in the endoplasmic reticulum (ER). this is a sole model for the drug-induced ER-associated degradation. On 1996, We identified that intracellular protein C synthesized in the presence of warfarin was associated with ER molecular chaperones such as GRP94, GRP78(BiP), and calreticulin on the course of intracellular degradation. Moreover, proteasomal inhibitors such as lactacystin and Z-leu-Leu-Leu-H inhibited the warfarin-induced degradation of protein C,suggesting that under-gamma-carboxylated protein C is Degraded by proteasome in cytosol through the retrograde transport. On 1997, We compared the warfarin-sensitivity among vitamin K-dependent proteins. Protein C synthesized in HepG2 cells was extensively degraded in the presence of warfarin, whereas-50% of prothrombin was secreted into medium. This results suggested that prothrombin Gla domain is moro resistant to warfarin than that of protein C.Then, we constructed two chimeras of protein C having prothrombin Gla domain (GDII/PC) and having prepro-sequence to Gladomain of prothrombin (PPGDII/PC), and examined the secretion of chimeras using BHK cells. Unexpectedly, both chimeric proteins were not secreted even in the presence of vitamin K.gamma-Carboxylation of chimeras was occurred normally. These results suggested that not only gamma-carboxylation in the Gla domain, but the interaction of certain Gla domain to other domains is also an important factor in quuality control of vitamin K-dependent proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kondo, S., et al.: "Molecular and Cellular Basis for Type Heparin Cofactor II Deficiency (Heparin Cofactor II Awaji)." Blood. 87(3). 1006-1012 (1996)
Kondo, S. 等人:“肝素辅因子 II 型缺乏症(肝素辅因子 II 淡路)的分子和细胞基础。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fuminori Tokunaga: "Snake Venom Enzymes" Alaken,Inc.,Fort Collins,CO, 18 (1998)
德永文典:“蛇毒酶”Alaken,Inc.,Fort Collins,CO, 18 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawabata, S., et al.: "Limulus Factor D,a 4-kDa Protein Isolated from Horseshoe Crab Hemocytes, is a Serine Protease Homologue with Antimicrobial Activity." FEBS Lett.398(1). 146-150 (1996)
Kawabata, S. 等人:“鲎因子 D,一种从鲎血细胞中分离出来的 4-kDa 蛋白质,是具有抗菌活性的丝氨酸蛋白酶同系物。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tokunaga, F., et al.: Endoplasmic Reticulum-associated Degradation of Protein C Precursor Synthesized in the Presence of Warfarin.Springer-Verlag, Tokyo, (1996)
Tokunaga, F. 等人:华法林存在下合成的蛋白 C 前体的内质网相关降解。Springer-Verlag,东京,(1996)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Koide, T., et al.: "Quality Control of Protein C : Protein C Synthesized in the Presence of Warfarin is Selectively Degraded in the Endoplasmic Reticulum." Pol.J.Pharmacol.48. 203-207 (1996)
Koide, T. 等人:“C 蛋白的质量控制:华法林存在下合成的 C 蛋白在内质网中选择性降解。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Identification of deubiquitinases, which regulate inflammatory and immune signaling pathways, and screening for their inhibitors
-
批准号:16K15210
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2016
-
负责人:TOKUNAGA Fuminori
-
依托单位:
Screening for interactors of linear ubiquitin chain assembly complex (LUBAC), and studies on their physiological functions
-
批准号:15H04694
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2015
-
负责人:TOKUNAGA Fuminori
-
依托单位:
Construction and application of linear ubiquitin-specific molecular probes for anti-cancer drug screening
-
批准号:25670137
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2013
-
负责人:TOKUNAGA Fuminori
-
依托单位:
Construction of polyubiquitin chain specific molecular probes and their applications to histopathologic examinations.
-
批准号:23657075
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2011
-
负责人:TOKUNAGA Fuminori
-
依托单位:
Investigation of physiological function of linear polyubiquitination using various biological models
-
批准号:23390070
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.73万
-
财政年份:2011
-
负责人:TOKUNAGA Fuminori
-
依托单位:
Relationship between inflammation and novel NF-κB activation pathway which is regulated by ubiquitin system
-
批准号:20390097
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.73万
-
财政年份:2008
-
负责人:TOKUNAGA Fuminori
-
依托单位:
Involvement of ubiquitin system on the hepatitis B virus X protein (HBx)-mediated transactivation activity
-
批准号:17590274
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2005
-
负责人:TOKUNAGA Fuminori
-
依托单位:
Effects of HOIL-1 ubiquitin ligase complex on the physiological function of hepatitis B virus X protein
-
批准号:15590279
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2003
-
负责人:TOKUNAGA Fuminori
-
依托单位:
Studies on cellular basis of the endoplasmic reticulum-associated degradation and intracellular aggregation of misfolded proteins
-
批准号:13680695
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.83万
-
财政年份:2001
-
负责人:TOKUNAGA Fuminori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
关于唐氏综合症关键区域1(DSCR1)蛋白降解途径及功能的研究
-
批准号:30771075
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2007
-
负责人:孙秀莲
-
依托单位:
细胞内磷酸化tau蛋白降解途径的研究
-
批准号:30500271
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2005
-
负责人:张家玉
-
依托单位:
脊髓小脑变性3型蛋白导致蛋白酶体功能障碍及其机制
-
批准号:30470538
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2004
-
负责人:王光辉
-
依托单位:
proteasome抑制剂诱导恶性增殖白血病细胞凋亡的分子机制
-
批准号:30100223
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2001
-
负责人:孙国敬
-
依托单位:
Ubiquitin-proteasome系统在多发性肌炎/皮肌炎发病机制中的作用
-
批准号:30170885
-
项目类别:面上项目
-
资助金额:16.0万元
-
批准年份:2001
-
负责人:王国春
-
依托单位: